Skip to Content


Focusing on Cancer's Most Lethal Aspect

Conquest - Summer 2009

By Scott Merville

Cancer Metastasis Research: Bench to Bedside is a one-of-a-kind graduate program that will begin this fall at The University of Texas Graduate School of Biomedical Sciences at Houston a combined program of M. D. Anderson and The University of Texas Health Science Center at Houston.

“Metastasis is far and away the major killer of cancer patients, and this doctoral program is the first to treat the study of metastasis as a separate discipline,” says program organizer Gary Gallick, Ph.D., professor and director of education in
M. D. Anderson’s Department of Genitourinary Medical Oncology and a member of the GSBS faculty.

The metastasis program integrates a traditional hypothesis-driven, basic-science research approach with M. D. Anderson’s strong emphasis on cultivating close collaborations among physicians and scientists.

Funded over the next three years by a $485,250 grant from UT System, the program was one of only seven recipients in a system-wide competition called the Graduate Program Institute. The UT System Board of Regents allocated $5 million for the initiative to cultivate innovative programs that will attract high-quality graduate students to UT System institutions.

“It’s crucial that we improve our basic understanding of the underlying mechanisms for the spread of cancer to distant sites,” says M. D. Anderson Provost and Executive Vice President Raymond DuBois, M.D., Ph.D. “The program will enhance the training of future scientists who will advance metastasis research.”

© 2015 The University of Texas MD Anderson Cancer Center